Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-33.84	125.20	189.25
Graham Fair Price	-73.06	10.55	39.14
PEG	365.21	-20.48	4.40
Price/Book	-2.26	1.07	1.09
Price/Cash Flow	-79.23	99.75	480.32
Prices/Earnings	1246.57	2195.74	-163.06
Price/Sales	-9.88	49.14	54.53
Price/FCF	-79.23	99.75	480.32
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-29.63	0.44	0.63
Operating Margin	63.77	-0.07	-0.19
ROA	-92.70	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-92.74
ROIC	< 0.005	< 0.005	-86.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.03	0.50	-94.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.18	0.61	233.88
EPS QOQ	0.37	1.07	189.46
FCF QOQ	0.82	3.69	350.44
Revenue QOQ	0.03	0.08	158.48
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.86	< 0.005	-100.00
Days Sales Outstanding (DSO)	192.19	190.44	-0.91
Inventory Turnover	31.42	154646000.00	492121255.06
Debt/Capitalization	< 0.005	< 0.005	-2.32
Quick Ratio	1.78	2.24	25.96
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	201.72	201.72	< 0.005
Cash	1.75	2.80	59.35
Capex	< 0.005	-0.02	-81.53
Free Cash Flow	0.46	2.16	370.65
Revenue	4.04	4.38	8.47
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.91	2.32	21.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.45	-0.76	-69.74
Naive Interpretation	Member

06 - Financial Health · Bad

Rating